Liver Life Walk has been a signature event of American Liver Foundation since 1999, said Lorraine Stiehl, Chief Executive Officer of ALF. Funds r ...

Gilead Sciences’ seladelpar has been granted conditional marketing authorisation by the European Commission (EC) to treat ...

Biliary tract cancer is increasing in incidence and mortality across Europe, with more people under the age of 60 years-old ...

Mirum Pharmaceuticals’ Ctexli (chenodiol) has gained US Food and Drug Administration (FDA) approval for treating adults with ...

Sian Ashcroft, a 35-year-old mother of three, died just 18 days after being diagnosed with terminal cholangiocarcinoma in January 2024. Despite initial misdiagnoses and being told she had months to ...

The global biliary stent market was valued at approximately USD 394.5 million in 2022 and is projected to grow at a healthy CAGR of over 5.5% during the forecast period from 2023 ...

Gilead Sciences, Inc. has received conditional marketing authorization from the European Commission (EC) for Seladelpar for the treatment of primary biliary cholangitis (PBC) ...

Daniel Bisogno, a renowned TV Azteca personality and co-host of the popular entertainment news program Ventaneando, has ...

"It is with deepest sadness that we regret to report news we never wanted to give," his beloved show shared in a social media ...

Chenodiol -- a naturally occurring human bile acid also known as chenodeoxycholic acid -- is the first FDA-approved drug indicated for the rare lipid storage disease and autosomal recessive genetic ...

The approval makes chenodiol—already cleared for decades to treat radiolucent gallstones under the brand name Chenodal—the ...